These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6994208)

  • 21. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of influenza and poliomyelitis with killed virus vaccines.
    Salk J; Salk D
    Science; 1977 Mar; 195(4281):834-47. PubMed ID: 320661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine.
    Prevots DR; Strebel PM
    Pediatr Ann; 1997 Jun; 26(6):378-83. PubMed ID: 9188130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
    Duintjer Tebbens RJ; Thompson KM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.
    Lasch EE; Abed Y; Abdulla K; El Tibbi AG; Marcus O; El Massri M; Handscher R; Gerichter CB; Melnick JL
    Rev Infect Dis; 1984; 6 Suppl 2():S467-70. PubMed ID: 6740094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possible method of eradication of poliomyelitis as an infection].
    Seĭbil' VB; Malyshkina LP
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):107-13. PubMed ID: 22830285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How poliomyelitis is to be eradicated completely].
    Seĭbil' VB
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):107-13. PubMed ID: 12043142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E; Sherrod JL
    J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine.
    Salk D; van Wezel AL; Salk J
    Lancet; 1984 Dec; 2(8415):1317-21. PubMed ID: 6150331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.
    Sutter RW; Pallansch MA; Sawyer LA; Cochi SL; Hadler SC
    Ann N Y Acad Sci; 1995 May; 754():289-99. PubMed ID: 7625665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D
    Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.
    Ion-Nedelcu N; Strebel PM; Toma F; Biberi-Moroeanu S; Combiescu M; Persu A; Aubert-Combiescu A; Plotkin SA; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S241-6. PubMed ID: 9203723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.